The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Candida albicans biofilms: building a heterogeneous, drug-tolerant environment
Abstract
Fungi are able to form biofilms on medical implants, causing serious infections. A better understanding of fungal biofilm formation is necessary to develop tools for detection or prevention and to identify new antifungal strategies. This review explores recent advances in the characterization at the molecular level of fungal biofilms, especially those formed by the yeast Candida albicans: the identification of complex transcriptional networks that control their formation; the pivotal role of the extracellular matrix in biofilm antifungal tolerance; and the knowledge gained on the physiology of biofilm cells and heterogeneity within these communities. These findings may help develop new, targeted therapeutic strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to the 6 master transcriptional regulators discussed above, another 44 transcriptional regulators have been identified; if any of these is deleted, some aspect of C. albicans biofilm formation is affected under at least one condition (Table 1; revised from 61 and 18).”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [18]
In the citing paper
“Current antifungal drugs have only two specific targets (ergosterol biosynthesis and 1,3-β-D-glucan synthesis)”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [18]
In the citing paper
“and it is widely believed that antifungal drugs with new mechanisms of action are needed (4, 18, 79).”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [18]
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167
Flemming, H.-C., & Wingender, J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2415 · Cited by 10,137
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644
Biofilms as Complex Differentiated Communities
Stoodley, P., Sauer, K., Davies, D. G., & Costerton, J. W. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.160705 · Cited by 3,151
Physiological heterogeneity in biofilms
Stewart, P. S., & Franklin, M. J. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1838 · Cited by 2,483
Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578
Evolving concepts in biofilm infections
Hall‐Stoodley, L., & Stoodley, P. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01323.x · Cited by 1,138
A Recently Evolved Transcriptional Network Controls Biofilm Development in Candida albicans
Nobile, C. J., Fox, E. P., Nett, J. E., Sorrells, T. R., Mitrovich, Q. M., Hernday, A. D., Tuch, B. B., Andes, D. R., & Johnson, A. D. (2012) · Cell · doi:10.1016/j.cell.2011.10.048 · Cited by 711
Genetic control of Candida albicans biofilm development
Finkel, J. S., & Mitchell, A. P. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2475 · Cited by 641
Biofilm formation by Candida species on the surface of catheter materials in vitro
Hawser, S. P., & Douglas, L. J. (1994) · Infection and Immunity · doi:10.1128/iai.62.3.915-921.1994 · Cited by 599
Flagged first, then by citations
Cited by
Sorted by citations
The Fungal Cell Wall: Structure, Biosynthesis, and Function
Gow, N. A. R., Latge, J.-P., & Munro, C. A. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.funk-0035-2016 · Cited by 1,423
Candida albicans Biofilms and Human Disease
Nobile, C. J., & Johnson, A. D. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104330 · Cited by 1,057
Candida albicans—The Virulence Factors and Clinical Manifestations of Infection
Talapko, J., Juzbašić, M., Matijević, T., Pustijanac, E., Bekić, S., Kotris, I., & Škrlec, I. (2021) · Journal of Fungi · doi:10.3390/jof7020079 · Cited by 794
“The biofilm cells form a hypoxic environment and increase the expression of genes involved in glycolysis, fatty acid metabolism, and ergosterol synthesis [45].”
BackgroundCandida albicans biofilms: development, regulation, and molecular mechanisms
Gulati, M., & Nobile, C. J. (2016) · Microbes and Infection · doi:10.1016/j.micinf.2016.01.002 · Cited by 738
Mechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647
Campoy, S., & Adrio, J. L. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.11.019 · Cited by 511
Emerging Threats in Antifungal-Resistant Fungal Pathogens
Sanglard, D. (2016) · Frontiers in Medicine · doi:10.3389/fmed.2016.00011 · Cited by 435
Cavassin, F. B., Baú-Carneiro, J. L., Boas, R. R. V., & Queiroz‐Telles, F. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-020-00382-7 · Cited by 403
Rosenberg, A., Ene, I. V., Bibi, M., Zakin, S., Segal, E. S., Ziv, N., Dahan, A. M., Colombo, A. L., Bennett, R. J., & Berman, J. (2018) · Nature Communications · doi:10.1038/s41467-018-04926-x · Cited by 270
Fungal Biofilms, Drug Resistance, and Recurrent Infection
Desai, J. V., Mitchell, A. P., & Andes, D. R. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019729 · Cited by 252
Fungal Biofilms and Polymicrobial Diseases
Costa-Orlandi, C. B., Sardi, J. D. C. O., Pitangui, N. D. S., de Oliveira, H. C., Scorzoni, L., Galeane, M. C., Medina‐Alarcón, K. P., Melo, W., Marcelino, M., Braz, J. D., et al. (2017) · Journal of Fungi · doi:10.3390/jof3020022 · Cited by 246
Polke, M., Hube, B., & Jacobsen, I. D. (2015) · Advances in applied microbiology · doi:10.1016/bs.aambs.2014.12.002 · Cited by 204
Candida albicans, plasticity and pathogenesis
Poulain, D. (2013) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2013.813904 · Cited by 188
An expanded regulatory network temporally controls C andida albicans biofilm formation
Fox, E. P., Bui, C. K., Nett, J. E., Hartooni, N., Mui, M. C., Andes, D. R., Nobile, C. J., & Johnson, A. D. (2015) · Molecular Microbiology · doi:10.1111/mmi.13002 · Cited by 173
Li, W., Shi, Q., Dai, H., Liang, Q. D., Xie, X., Huang, X.-M., Zhao, G.-Z., & Zhang, L. (2016) · Scientific Reports · doi:10.1038/srep22805 · Cited by 138
Tackling Fungal Resistance by Biofilm Inhibitors
Wu, S., Wang, Y., Liu, N., Dong, G., & Sheng, C. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01203 · Cited by 134
pH Signaling in Human Fungal Pathogens: a New Target for Antifungal Strategies
Cornet, M., & Gaillardin, C. M. (2014) · Eukaryotic Cell · doi:10.1128/ec.00313-13 · Cited by 101
Romo, J. A., & Kumamoto, C. A. (2020) · Journal of Fungi · doi:10.3390/jof6010016 · Cited by 106
Strength in numbers: antifungal strategies against fungal biofilms
Ramage, G., Robertson, S. N., & Williams, C. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.10.023 · Cited by 89
The Fungal Cell Wall: Structure, Biosynthesis, and Function
Gow, N. A. R., Latgé, J., & Munro, C. A. (2017) · ASM Press eBooks · doi:10.1128/9781555819583.ch12 · Cited by 92
Morici, P., Fais, R., Rizzato, C., Tavanti, A., & Lupetti, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167470 · Cited by 73
Chitosan-Based Drug Delivery Systems for Optimization of Photodynamic Therapy: a Review
Calixto, G. M. F., de Annunzio, S. R., Victorelli, F. D., Frade, M. L., Ferreira, P. S., Chorilli, M., & Fontana, C. R. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-019-1407-y · Cited by 71
Assessment and Optimizations of Candida albicans In Vitro Biofilm Assays
Lohse, M. B., Gulati, M., Arevalo, A. V., Fishburn, A. T., Johnson, A. D., & Nobile, C. J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02749-16 · Cited by 68
Wang, S., Wang, Y., Liu, W., Liu, N., Zhang, Y., Dong, G., Liu, Y., Li, Z., He, X., Miao, Z., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400492t · Cited by 63
Cabral, V., Znaidi, S., Walker, L. A., Martin-Yken, H., Dague, E., Legrand, M., Lee, K., Chauvel, M., Firon, A., Rossignol, T., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004542 · Cited by 59
Self-citationGong, Y., Liu, W., Huang, X., Hao, L., Li, Y., & Sun, S. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01461 · Cited by 58
Soldini, S., Posteraro, B., Vella, A., Carolis, E. D., Borghi, E., Falleni, M., Losito, A. R., Maiuro, G., Trecarichi, E. M., Sanguinetti, M., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.11.005 · Cited by 57
Antimicrobial Properties of Antidepressants and Antipsychotics—Possibilities and Implications
Caldara, M., & Marmiroli, N. (2021) · Pharmaceuticals · doi:10.3390/ph14090915 · Cited by 54
Identification of the cell targets important for propolis-induced cell death in Candida albicans
de Castro, P. A., Bom, V. L. P., Brown, N. A., Almeida, R. S., Ramalho, L. N. Z., Savoldi, M., Goldman, M. H. S., Berretta, A. A., & Goldman, G. H. (2013) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2013.07.001 · Cited by 54
Biofilm formation inCandida glabrata: What have we learnt from functional genomics approaches?
d’Enfert, C., & Janbon, G. (2015) · FEMS Yeast Research · doi:10.1093/femsyr/fov111 · Cited by 58
Self-citationNocedal, I., Mancera, E., & Johnson, A. D. (2017) · eLife · doi:10.7554/elife.23250 · Cited by 54
Cheeseman, S., Shaw, Z. L., Vongsvivut, J. P., Crawford, R. J., Dupont, M. F., Boyce, K. J., Gangadoo, S., Bryant, S. J., Bryant, G., Cozzolino, D., et al. (2021) · Molecules · doi:10.3390/molecules26133890 · Cited by 51
Jangjou, A., Zareshahrabadi, Z., Abbasi, M., Talaiekhozani, A., Kamyab, H., Chelliapan, S., Vaez, A., Golchin, A., Tayebi, L., Vafa, E., et al. (2022) · Sustainability · doi:10.3390/su141912942 · Cited by 52
Ene, I. V., Lohse, M. B., Vladu, A., Morschhäuser, J., Johnson, A. D., & Bennett, R. J. (2016) · mBio · doi:10.1128/mbio.01269-16 · Cited by 50
Analysis of the Candida albicans Phosphoproteome
Willger, S. D., Liu, Z., Olarte, R. A., Adamo, M. E., Stajich, J., Myers, L. C., Kettenbach, A. N., & Hogan, D. A. (2015) · Eukaryotic Cell · doi:10.1128/ec.00011-15 · Cited by 48
Affinity molecular assay for detecting Candida albicans using chitin affinity and RPA-CRISPR/Cas12a
Shen, S., Wang, W., Ma, Y., Wang, S., Zhang, S., Cai, X.-F., Chen, L., Zhang, J., Li, Y., Wu, X., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53693-5 · Cited by 46
Inhibition of Candida albicans virulence factors by novel levofloxacin derivatives
Shafreen, R. B., Muthamil, S., & Pandian, S. K. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-5719-2 · Cited by 42
Binkley, J., Arnaud, M. B., Inglis, D. O., Skrzypek, M. S., Shah, P., Wymore, F., Binkley, G., Miyasato, S. R., Simison, M., & Sherlock, G. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1046 · Cited by 41
Biatriosporin D displays anti-virulence activity through decreasing the intracellular cAMP levels
Zhang, M., Chang, W., Shi, H., Zhou, Y., Zheng, S., Li, Y., Li, L., & Lou, H. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.03.004 · Cited by 40
Interaction of the Rattlesnake Toxin Crotamine with Model Membranes
Costa, B. A., Sanches, L., Gomide, A. B., Bizerra, F. C., Mas, C. D., Oliveira, E. B., Perez, K. R., Itri, R., Oguiura, N., & Hayashi, M. A. F. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp411886u · Cited by 34
Strategies in the Discovery of Novel Antifungal Scaffolds
Liu, N., Wang, C., Su, H., Zhang, W., & Sheng, C. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0020 · Cited by 34
Verma‐Gaur, J., Qu, Y., Harrison, P. F., Lo, T. L., Quenault, T., Dagley, M. J., Belousoff, M. J., Powell, D., Beilharz, T. H., & Traven, A. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005590 · Cited by 33
Santos, R., Costa, C., Mil‐Homens, D., Romão, D., de Carvalho, C. C. C. R., Pais, P., Mira, N. P., Fialho, A. M., & Teixeira, M. C. (2016) · Cellular Microbiology · doi:10.1111/cmi.12686 · Cited by 34
Camilli, G., Eren, E., Williams, D. L., Aimanianda, V., Meunier, É., & Quintin, J. (2018) · European Journal of Immunology · doi:10.1002/eji.201747224 · Cited by 33
Raman, N., Lee, M., Lynn, D. M., & Palecek, S. P. (2015) · Pharmaceuticals · doi:10.3390/ph8030483 · Cited by 28
Seddiki, S. M. L., Boucherit‐Otmani, Z., Boucherit, K., & Kunkel, D. D. (2015) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2015.03.003 · Cited by 28
Zoysa, G. H. D., Glossop, H. D., & Sarojini, V. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.01.023 · Cited by 28
Klis, F. M., & Brul, S. (2015) · Eukaryotic Cell · doi:10.1128/ec.00142-15 · Cited by 27
Rapidly Developing Yeast Microcolonies Differentiate in a Similar Way to Aging Giant Colonies
Váchová, L., Hatáková, L., Čáp, M., Pokorná, M., & Palková, Z. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/102485 · Cited by 26
Combination of Posaconazole and Amphotericin B in the Treatment of Candida glabrata Biofilms
Rodrigues, C. F., Alves, D. F., & Henriques, M. (2018) · Microorganisms · doi:10.3390/microorganisms6040123 · Cited by 26
The trans-kingdom identification of negative regulators of pathogen hypervirulence
Brown, N. A., Urban, M., & Hammond-Kosack, K. E. (2015) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuv042 · Cited by 25
de Vasconcellos, A. A., Gonçalves, L., Cury, A. A. D. B., & da Silva, W. D. (2014) · Microbial Pathogenesis · doi:10.1016/j.micpath.2014.03.009 · Cited by 23
Faria‐Oliveira, F., Carvalho, J., Ferreira, C., Hernáez, M. L., Gil, C., & Lucas, C. (2015) · BMC Microbiology · doi:10.1186/s12866-015-0550-1 · Cited by 21
Wang, Y. (2016) · The Journal of Microbiology · doi:10.1007/s12275-016-5550-9 · Cited by 22
Romo, J. A., Zhang, H., Cai, H., Kadosh, D., Köhler, J. R., Saville, S. P., Wang, Y., & Lopez-Ribot, J. L. (2019) · mSphere · doi:10.1128/msphere.00620-19 · Cited by 21
Villa, F., Villa, S., Gelain, A., & Cappitelli, F. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113136660225 · Cited by 21
Rewak-Soroczyńska, J., Paluch, E., Siebert, A., Szałkiewicz, K., & Obłąk, E. (2019) · Letters in Applied Microbiology · doi:10.1111/lam.13195 · Cited by 21
A Comprehensive Overview of Candida albicans as the Leading Pathogen in Vulvovaginal Candidiasis
Srb, N., Talapko, J., Meštrović, T., Fureš, R., Stupnišek, M., Srb, A. M., & Škrlec, I. (2025) · Journal of Fungi · doi:10.3390/jof11090632 · Cited by 26
Tang, N., Yuan, S., Luo, Y., Wang, A.-J., Sun, K., Liu, N., & Tao, K. (2023) · ACS Omega · doi:10.1021/acsomega.2c07740 · Cited by 20
Anti-Biofilm Activity of Assamsaponin A, Theasaponin E1, and Theasaponin E2 against Candida albicans
Chen, Y., Gao, Y., Li, Y., & Yin, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073599 · Cited by 21
Candida albicans Niche Specialization: Features That Distinguish Biofilm Cells from Commensal Cells
Herwald, S. E., & Kumamoto, C. A. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0178-x · Cited by 20
Curvelo, J. A. D. R., de Moraes, D. C., ANJOS, C. A. D., Portela, M. B., & Soares, R. M. A. (2019) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201920180045 · Cited by 19
Biofilm: A Robust and Efficient Barrier to Antifungal Chemotherapy
Souza dos Santos, A. L., & de Mello, T. P. (2015) · Journal of Antimicrobial Agents · doi:10.4172/2472-1212.1000e101 · Cited by 18
Chromatin Structure and Drug Resistance in Candida spp.
O’Kane, C. J., Weild, R., & Hyland, E. M. (2020) · Journal of Fungi · doi:10.3390/jof6030121 · Cited by 19
Wirtanen, G., & Salo, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-08-100155-4.00005-4 · Cited by 22
Application of 460�nm visible light for the elimination of Candida�albicans in�vitro and in�vivo
Wang, C., Yang, Z., Peng, Y., Guo, Y., Yao, M., & Dong, J. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9196 · Cited by 17
Li, Y., Shan, M., Yan, M., Yao, H., Wang, Y., Gu, B., Zhu, Z., & Li, H. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02844 · Cited by 16
Transcriptomic meta-analysis to identify potential antifungal targets in Candida albicans
Hefny, Z. A., Ji, B., Elsemman, I. E., Nielsen, J., & Dijck, P. V. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03213-8 · Cited by 17
Sexual biofilm formation in C andida tropicalis opaque cells
Jones, S. K., Hirakawa, M. P., & Bennett, R. J. (2014) · Molecular Microbiology · doi:10.1111/mmi.12565 · Cited by 15
The role of Mss11 in Candida albicans biofilm formation
Tsai, P.-W., Chen, Y.-T., Yang, C., Chen, H.-F., Tan, T.-S., Lin, T.-W., Hsieh, W., & Lan, C. (2014) · Molecular Genetics and Genomics · doi:10.1007/s00438-014-0846-0 · Cited by 13
Portela, M., de Amorim, E. L., dos Santos, A. M., Curvelo, J. A. D. R., Martins, K. D. O., Capillé, C. L., Soares, R. M. D. A., & Castro, G. F. B. D. A. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2016.11.020 · Cited by 12
A patent review of antibiofilm fungal drugs (2002-present)
Serafini, M. R., Santos, V. V., Torres, B. G. S., Azeredo, F. J., Savi, F. M., & Alves, I. A. (2021) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2021.1874283 · Cited by 11
Wang, F., Wu, J., Yuan, M., Yan, Z., Liu, X., Li, W., Zhang, Y., Sheng, C., Liu, N., & Huang, Z. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01308 · Cited by 11
Touil, H. F. Z., Boucherit‐Otmani, Z., & Boucherit, K. (2018) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2018.06.008 · Cited by 10
Kim, D., & Kim, K.-Y. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258108 · Cited by 10
Martínez, J. P., Blanes, R., Casanova, M., Valentı́n, E., Murgui, A., & Domínguez, Á. (2016) · FEMS Yeast Research · doi:10.1093/femsyr/fow075 · Cited by 10
Plasma activated Ezhangfeng Cuji as innovative antifungal agent and its inactivation mechanism
Lin, L., Zhuo, Y., Dong, Q., Yang, C., Cheng, C., & Liu, T. (2023) · AMB Express · doi:10.1186/s13568-023-01571-6 · Cited by 9
Gaining More Insight into the Determinants of Candida Species Pathogenicity in the Oral Cavity
Arzmi, M. H., AlShwaimi, E., Himratul-Aznita, W. H., Razak, F. B. A., Farina, F., McCullough, M. J., & Cirillo, N. (2014) · European Journal of Inflammation · doi:10.1177/1721727x1401200202 · Cited by 8
Influence of Zinc on Histoplasma capsulatum Planktonic and Biofilm Cells
Pires, A. C. M. D. S., Carvalho, A. R., Vaso, C. O., Mendes‐Giannini, M. J. S., Singulani, J. D. L., & Fusco‐Almeida, A. M. (2024) · Journal of Fungi · doi:10.3390/jof10050361 · Cited by 7
Mechanisms of Drug Resistance in Candida albicans
Sanglard, D. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_15 · Cited by 7
Campos, R. D. S., da Silva, C. R., Neto, J. B. D. A., Sampaio, L. S., do Nascimento, F. B. S. A., de Moraes, M. O., Cavalcanti, B. C., Magalhães, H. I. F., Gomes, A. O. C. V., Lobo, M. D. P., et al. (2018) · International Journal of Current Microbiology and Applied Sciences · doi:10.20546/ijcmas.2018.702.435 · Cited by 7
Pezzotti, G., Adachi, T., Imamura, H., Ikegami, S., Kitahara, R., Yamamoto, T., Kanamura, N., Zhu, W., Ishibashi, K., Okuma, K., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111410 · Cited by 6
Sundararajan, A., Rane, H. S., Ramaraj, T., Sena, J. A., Howell, A. B., Bernardo, S. M., Schilkey, F., & Lee, S. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201969 · Cited by 6
Azole Antifungal Drugs: Mode of Action and Resistance
Garcia‐Rubio, R., Monteiro, M. C., & Mellado, E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.20731-0 · Cited by 9
Maskarinec, S. A., Parlak, Z., Tu, Q., Levering, V. W., Zauscher, S., López, G. P., Fowler, V. G., & Perfect, J. R. (2018) · Biofouling · doi:10.1080/08927014.2018.1474461 · Cited by 5
Silva, M. P., de Barros, P. P., Jorjão, A. L., Rossoni, R. D., Junqueira, J. C., & Jorge, A. O. C. (2019) · Brazilian Dental Science · doi:10.14295/bds.2019.v22i2.1692 · Cited by 5
Induction of Antifungal Tolerance Reveals Genetic and Phenotypic Changes in Candida glabrata
Chedraoui, C., Fattouh, N., Hachem, S. E., Younes, M., & Khalaf, R. A. (2025) · Journal of Fungi · doi:10.3390/jof11040284 · Cited by 4
Biçer, M. (2023) · Archives of Microbiology · doi:10.1007/s00203-023-03744-0 · Cited by 4
Candida Biofilm: Clinical Implications of Recent Advances in Research
Press, E. G., Shields, R. K., & Clancy, C. J. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0176-z · Cited by 4
Candida albicans: Clinical Relevance, Pathogenesis, and Host Immunity
Correia, A., Sampaio, P., Vilanova, M., & Pais, C. (2015) · Wiley eBooks · doi:10.1002/9781118644843.ch50 · Cited by 4
Role of Antifungal Drugs in Combating Invasive Fungal Diseases
Dutt, K. (2019) · Wiley eBooks · doi:10.1002/9781119460053.ch5 · Cited by 4
Zhang, C., Liu, J., Jiang, Y. N., & Sun, S. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.01520-25 · Cited by 4
Preventing Candida albicans biofilm formation using aromatic-rich piperazines
Simon, G., Bérubé, C., Paquet-Côté, P.-A., Grenier, D., & Voyer, N. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115810 · Cited by 3
Fungal Biofilms: Formation, Resistance and Pathogenicity
Sardi, J. D. C. O., de Souza, N., Gullo, F. P., Fusco‐Almeida, A. M., & Mendes‐Giannini, M. J. S. (2015) · CRC Press eBooks · doi:10.1201/b18707-17 · Cited by 3
Antifungal Resistance and its Evolution: An Increasing Concern
Ortíz, C. (2018) · Advances in Biotechnology & Microbiology · doi:10.19080/aibm.2018.10.555777 · Cited by 3
Schöpf, C., Geschwindt, A., Knapp, M., Seybold, A., Coraça-Huber, D. C., Ausserlechner, M. J., Romanelli, A., & Marx, F. (2025) · Journal of Fungi · doi:10.3390/jof12010011 · Cited by 2
Animal Infections: The Role of Fungal Biofilms
Yadav, M., & Malvi, Y. (2019) · Fungal biology · doi:10.1007/978-3-030-18586-2_10 · Cited by 1
Biofilm Formation and its Impact on Antifungal Therapy
Müller, F. C. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0194-x · Cited by 2
Sadik, O., Diţu, L.-M., Gheorghe, I., Holban, A. M., Curuțiu, C., Pîrcălăbioru, G. G., Avram, I., Banu, O., Al-mahdawy, O., Alkurjia, D. A., et al. (2019) · Revista română de medicină de laborator · doi:10.2478/rrlm-2019-0007 · Cited by 2
Ali, I. S. F. A., Amin, M. F., Abo-Ghabsha, M. A., & El-Garhy, A. M. (2021) · Al-Azhar Medical Journal · doi:10.21608/amj.2021.139842 · Cited by 2
Metadata
- Authors
- Bonhomme, J., & d’Enfert, C.
- Affiliations
- Centre Hospitalier Universitaire de Caen Normandie (FR)
- Institut Pasteur (FR)
- Corresponding author
- d’Enfert, Christophe
- Venue
- Current Opinion in Microbiology
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 16
- Issue
- 4
- Pages
- 398-403
- ISSN
- 1369-5274 (ISSN-L)
- OpenAlex
- W2077255553
- Cited by
- 120
- References
- 53
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 7 · 2023: 7 · 2022: 1 · 2021: 8 · 2020: 4 · 2019: 11 · 2018: 11 · 2017: 9 · 2016: 12 · 2015: 16 · 2014: 16 · 2013: 6
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Microbiology (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-08-MIE-033-01, ANR-10-01)
- French Government's Investissement d’Avenir program, Laboratoire d’Excellence (ANR-10-LABX-62-IBEID)
- European Commission (PITN-GA-2008-214004)
- Fondation pour la Recherche Médicale (DEA20080713005)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Keywords
- Candida albicans, fungal biofilms, biofilm heterogeneity, antifungal drug tolerance, extracellular matrix, transcriptional regulatory networks, biofilm physiology, medical device infections
- MeSH terms
- Antifungal Agents, Candida albicans, Drug Tolerance, Biofilms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review